Exscientia Ltd is a biotechnology company that specializes in the application of artificial intelligence and machine learning to drug discovery and development

By leveraging advanced computational techniques, Exscientia aims to accelerate the identification and optimization of new therapeutic compounds, ultimately enhancing the efficiency and effectiveness of the drug development process. The company's innovative approach not only focuses on discovering novel drugs but also tailors them to the specific needs of patients, thereby aiming to improve treatment outcomes across various disease areas. Through collaborations with pharmaceutical companies and research institutions, Exscientia is at the forefront of transforming traditional drug development methodologies into a more data-driven and targeted approach.